
Research Square (Research Square), Год журнала: 2023, Номер unknown
Опубликована: Авг. 29, 2023
Язык: Английский
Research Square (Research Square), Год журнала: 2023, Номер unknown
Опубликована: Авг. 29, 2023
Язык: Английский
Biomedicines, Год журнала: 2023, Номер 11(5), С. 1254 - 1254
Опубликована: Апрель 23, 2023
Spinal muscular atrophy (SMA) is a neuromuscular disease resulting from mutations or deletions in SMN1 that lead to progressive death of alpha motor neurons, ultimately leading severe muscle weakness and atrophy, as well premature the absence treatment. Recent approval SMN-increasing medications SMA therapy has altered natural course disease. Thus, accurate biomarkers are needed predict severity, prognosis, drug response, overall treatment efficacy. This article reviews novel non-targeted omics strategies could become useful clinical tools for patients with SMA. Proteomics metabolomics can provide insights into molecular events underlying progression response. High-throughput data have shown untreated different profiles than controls. In addition, who clinically improved after profile those did not. These results glimpse on potential markers assist identifying responders, tracing disease, predicting its outcome. studies been restricted by limited number patients, but approaches feasible unravel severity-specific neuro-proteomic metabolic signatures.
Язык: Английский
Процитировано
16Mediators of Inflammation, Год журнала: 2023, Номер 2023, С. 1 - 17
Опубликована: Июль 31, 2023
Immune regulation plays a crucial role in human health and disease. Inflammatory bowel disease (IBD) is chronic relapse with an increasing incidence worldwide. Clinical treatments for IBD are limited inefficient. However, the pathogenesis of immune-mediated remains unclear. This review describes activation innate adaptive immune functions by intestinal cells to regulate balance maintain mucosal integrity. Changes susceptible genes, autophagy, energy metabolism, other factors interact complex manner system, eventually leading imbalance onset IBD. These events indicate that alarm development, further opening new possibilities unprecedented development immunotherapy
Язык: Английский
Процитировано
16International Journal of Oncology, Год журнала: 2023, Номер 62(3)
Опубликована: Фев. 16, 2023
The worldwide COVID‑19 pandemic was brought on by a new coronavirus (SARS Cov‑2). A marker/receptor called Dipeptidyl peptidase 4/CD26(DPP4/CD26) may be crucial in determining susceptibility to tumors and coronaviruses. However, the regulation of DPP4 COVID‑invaded cancer patients its role small molecule compounds remain unclear. present study used Human Protein Atlas, Monaco, Schmiedel databases analyze expression human tissues immune cells. association between survival various tumor compared using GEPIA 2. DNMIVD database correlation promoter methylation tumors. On cBioPortal network, frequency DPP4 DNA mutations cancers analyzed. immunomodulators analyzed TISIDB database. inhibitory effects cordycepin (CD), N6, N6‑dimethyladenosine (m62A) adenosine (AD) cells were evaluated. mainly expressed endocrine tissue, followed gastrointestinal tract, female tissue (mainly placenta), male prostate seminal vesicle), proximal digestive kidney, bladder, liver, gallbladder respiratory system. In cells, mRNA T upregulated esophageal carcinoma, kidney renal papillary cell carcinoma (KIRP), liver hepatocellular (LIHC), lung adenocarcinoma, pancreatic stomach thyroid thymoma. it downregulated breast invasive chromophobe, squamous skin cutaneous melanoma. Thus, is involved viral invasion most types cancer. could inhibited CD, m62A AD different Moreover, CD significantly formation GFP‑positive syncytial In vivo experiments with injection further showed that lymphocyte activating factor 3 expression. These drugs have potential treat targeting DPP4. medically significant for SARS‑CoV‑2‑infected patients, providing prospective novel targets concepts creation against COVID‑19.
Язык: Английский
Процитировано
13Cells, Год журнала: 2025, Номер 14(5), С. 387 - 387
Опубликована: Март 6, 2025
In recent years, new drugs for the treatment of type 2 diabetes (T2D) have been proposed, including glucagon-like peptide 1 (GLP-1) agonists or sodium–glucose cotransporter (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors. Over time, some these agents (in particular, GLP-1 SGLT2 inhibitors), which were initially developed their glucose-lowering actions, demonstrated significant beneficial pleiotropic effects, thus expanding potential therapeutic applications. This review aims to discuss mechanisms, GLP-1, DPP-4, SGLT2, with a particular focus on cardiorenal benefits beyond glycemic control.
Язык: Английский
Процитировано
0Molecular Nutrition & Food Research, Год журнала: 2025, Номер unknown
Опубликована: Март 13, 2025
ABSTRACT Insulin resistance is a common metabolic disease, and its pathogenesis still unclear. The decrease of glucagon‐like peptide‐1 (GLP‐1) level mediated by the alteration gut microbiota may be pathogenesis. study was to investigate regulatory effect dihydromyricetin (DHM) on GLP‐1 insulin induced high‐fat diet (HFD), further explore possible molecular mechanism. Mice were fed an HFD establish model determine whether DHM had protective effect. could improve resistance. increased serum improving intestinal secretion inhibiting decomposition, associated with intraepithelial lymphocytes (IELs) proportions decreased expression CD26 in IELs TCRαβ + CD8αβ HFD‐induced mice. ameliorate modulation metabolites, particularly regulation chenodeoxycholic acid (CDCA) content, followed inhibition farnesoid X receptor (FXR) L cells glucagon gene (Gcg) mRNA secretion. This research demonstrates role “gut microbiota‐CDCA” pathway improvement levels mice administration, providing new target for prevention
Язык: Английский
Процитировано
0Journal of Controlled Release, Год журнала: 2023, Номер 365, С. 759 - 772
Опубликована: Дек. 14, 2023
Язык: Английский
Процитировано
9International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(17), С. 9635 - 9635
Опубликована: Сен. 5, 2024
Angiotensin-converting enzyme 2 (ACE2) is considered a severe acute respiratory syndrome coronavirus (SARS-CoV-2) receptor of high importance, but due to its non-ubiquitous expression, studies other proteins that may participate in virus internalisation have been undertaken. To date, many alternative receptors discovered. Their functioning provide an explanation for some the events observed COVID-19 cannot be directly explained by model which ACE2 constitutes central point infection. Diabetes mellitus type (T2D) can induce development. Although mechanisms associated with lead increased SARS-CoV-2 virulence diabetes, such as basigin (CD147), glucose-regulated protein 78 kDa (GRP78), cluster differentiation 4 (CD4), transferrin (TfR), integrins α5β1/αvβ3, or co-receptors neuropilin (NRP2), vimentin, and even syalilated gangliosides also responsible worsening course. On hand, others play protective roles. Understanding how diabetes-associated via modification needs further extensive studies.
Язык: Английский
Процитировано
3F1000Research, Год журнала: 2024, Номер 13, С. 126 - 126
Опубликована: Фев. 20, 2024
Язык: Английский
Процитировано
1Medicine, Год журнала: 2024, Номер 103(22), С. e38367 - e38367
Опубликована: Май 31, 2024
This study aimed to decipher the interaction between CD26 and caveolin-1, key proteins involved in cell signaling linked various diseases. Using computational methods, we predicted their binding conformations assessed stability through 100 ns molecular dynamics (MD) simulations. We identified two distinct (con1 con4), with con1 exhibiting superior stability. In con1, specific amino acids CD26, namely GLU237, TYR241, TYR248, ARG147, were observed engage interactions F-J chain of Caveolin-1, establishing hydrogen bonds cation or π-π interactions. Meanwhile, con4, ARG253, LYS250, TYR248 interacted J Caveolin-1 via bonds, cation-π interactions, Virtual screening also revealed potential small-molecule modulators, including Crocin, Poliumoside, Canagliflozin, that could impact this interaction. Additionally, predictive analyses conducted on bioactivity, drug-likeness, ADMET properties these three compounds. These findings offer valuable insights into mechanism, paving way for new therapeutic strategies. However, further validation is required before clinical application. summary, provide a detailed understanding caveolin-1 interaction, identifying essential developing targeted therapies.
Язык: Английский
Процитировано
1Expert Opinion on Investigational Drugs, Год журнала: 2024, Номер 33(8), С. 791 - 799
Опубликована: Июль 8, 2024
Steroid-refractory acute graft-versus-host disease (SR-aGVHD) remains a formidable obstacle in the field of allogeneic hematopoietic cell transplantation (allo-HCT), significantly contributing to patient morbidity and mortality. The current therapeutic landscape for SR-aGVHD is limited, often yielding suboptimal results, thereby emphasizing urgent need innovative effective treatments.
Язык: Английский
Процитировано
1